News & Events

admin-ajax

RESI Conference

September 17, 2014
Fenway Park, Boston, MA

http://tinyurl.com/pj68bqb

 …

bbc-logo

NY/NJ CEO Conference

November 12-13, 2014
Apella, NY

http://tinyurl.com/q9jtsvs…

BEU14_logo_150x75

BIO-Europe 2014 – Presentation

November 3-5, 2014
Portalhaus Messe Frankfurt, Germany

http://tinyurl.com/24hv85e

 …

logo

Flemish Biotech and Life Sciences week (Japan)

October 14 – 20, 2014
Japan

http://tinyurl.com/q5dk7zh

 …

Bio Investor Forum

BIO Investor Forum – Presentation

October 7-8, 2014
The Palace Hotel, San Francisco

http://tinyurl.com/odqbgb5

 …

sachs_associates

14th Annual Biotech in Europe Forum for Global Partnering & Investment – Presentation

30 September – 1 October 2014
Congress Center Basel, Switzerland

http://tinyurl.com/mr43yxh

 …

actogenix_press_06

STALLERGENES and ActoGeniX to develop together an innovative new class of oral treatments for allergy

STALLERGENES to develop and commercialize novel oral allergy drugs based on ActoGeniX’s proprietary local mucosal delivery technology
ActoGeniX eligible for…

actogenix_press_06

ActoGeniX closes EUR 10.7 million financing round

Ghent, Belgium – April 18th, 2013

ActoGeniX, a clinical stage biopharmaceutical company, successfully closed a Series B equity financing round, …

flandersbio

Knowledge for Growth – Presentation

May 30, 2013
ICC Ghent

http://knowledgeforgrowth.be/

actogenix_press_01

ActoGeniX enters Research Collaboration with Merck

Ghent, Belgium – November 12, 2012

ActoGeniX, a clinical stage biopharmaceutical company, today announces the signing of a research collaboration …